216 related articles for article (PubMed ID: 3600207)
1. Net lipid transfer between lipoproteins in fish-eye disease plasma supplemented with normal high density lipoproteins.
Holmquist L; Carlson LA
Lipids; 1987 May; 22(5):305-11. PubMed ID: 3600207
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency.
Sparks DL; Frohlich J; Pritchard PH
Clin Chem; 1988 Sep; 34(9):1812-5. PubMed ID: 3416429
[TBL] [Abstract][Full Text] [Related]
3. Normalization of high density lipoprotein in fish eye disease plasma by purified normal human lecithin: cholesterol acyltransferase.
Holmquist L; Carlson LA
Lipids; 1988 Mar; 23(3):225-9. PubMed ID: 3374277
[TBL] [Abstract][Full Text] [Related]
4. Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease.
Carlson LA; Holmquist L
Acta Med Scand; 1985; 218(2):189-96. PubMed ID: 4061122
[TBL] [Abstract][Full Text] [Related]
5. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease.
Assmann G; Schmitz G; Heckers H
Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282
[TBL] [Abstract][Full Text] [Related]
6. Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
Carlson LA; Holmquist L; Assmann G
Acta Med Scand; 1987; 222(4):345-50. PubMed ID: 3425387
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lecithin:cholesterol acyltransferase deficiency. Lack of both phospholipase A2 and acyltransferase activities characteristic of high density lipoprotein lecithin:cholesterol acyltransferase in fish eye disease.
Holmquist L; Carlson LA
Acta Med Scand; 1987; 222(1):23-6. PubMed ID: 3630775
[TBL] [Abstract][Full Text] [Related]
8. In vitro normalization of cholesteryl ester content and particle size of fish eye disease high density lipoproteins.
Holmquist L; Carlson LA
Acta Med Scand; 1987; 221(3):283-9. PubMed ID: 3591466
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of normal high density lipoproteins on lecithin:cholesterol acyltransferase activity in fish eye disease plasma.
Holmquist L; Carlson LA
Acta Med Scand; 1987; 222(1):15-21. PubMed ID: 3630774
[TBL] [Abstract][Full Text] [Related]
10. Study of the components of reverse cholesterol transport in lecithin:cholesterol acyltransferase deficiency.
Park MS; Kudchodkar BJ; Frohlich J; Pritchard H; Lacko AG
Arch Biochem Biophys; 1987 Nov; 258(2):545-54. PubMed ID: 3674887
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of HDL subfractions towards lecithin-cholesterol acyltransferase. Modulation by their content in free cholesterol.
Simard G; Loiseau D; Girault A; Perret B
Biochim Biophys Acta; 1989 Oct; 1005(3):245-52. PubMed ID: 2804054
[TBL] [Abstract][Full Text] [Related]
12. Biochemical studies in a patient with a Tangier syndrome.
Yao JK; Herbert PN; Fredrickson DS; Ellefson RD; Heinen RJ; Forte T; Dyck PJ
J Neuropathol Exp Neurol; 1978; 37(2):138-54. PubMed ID: 632844
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of lecithin:cholesterol acyltransferase on apolipoprotein distribution in familial lecithin:cholesterol acyltransferase deficiency.
Glomset JA; Mitchell CD; King WC; Applegate KA; Forte T; Norum KR; Gjone E
Ann N Y Acad Sci; 1980; 348():224-43. PubMed ID: 6930928
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects.
Carlson LA; Holmquist L
Acta Med Scand; 1985; 218(2):197-205. PubMed ID: 4061123
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency.
Frohlich J; McLeod R; Pritchard PH; Fesmire J; McConathy W
Metabolism; 1988 Jan; 37(1):3-8. PubMed ID: 3121980
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasma lecithin:cholesterol acyltransferase in man. III. Role of high density lipoprotein cholesteryl esters in the activating effect of a high-fat test meal.
Rose HG; Juliano J
J Lipid Res; 1979 Mar; 20(3):399-407. PubMed ID: 221605
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
[TBL] [Abstract][Full Text] [Related]
18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
19. Lecithin:cholesterol acyltransferase activity in relation to lipoprotein concentration and lipid composition.
Leiss O; Murawski U; Egge H
Scand J Clin Lab Invest Suppl; 1978; 150():77-84. PubMed ID: 218279
[No Abstract] [Full Text] [Related]
20. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases.
Deckelbaum RJ; Eisenberg S; Oschry Y; Granot E; Sharon I; Bengtsson-Olivecrona G
J Biol Chem; 1986 Apr; 261(11):5201-8. PubMed ID: 3957920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]